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Heterogeneity in physical activity habits is 
relevant to clinical cardiovascular (CV) practice 
on a patient-by-patient basis. Routine physical 
activity is an effective way to increase longevity 
and to reduce the risk of CV disease (CVD). It is 
now the standard of care to counsel sedentary or 
inadequately active patients to increase physical 
activity for both the primary and secondary preven-
tion of CVD. In addition, recent data suggesting 
that high levels of physical activity may lead to 
significant CV consequences have led highly active 
patients and their clinicians to question the risk/
benefit ratio of high exercise dose exposure.
Higher levels of physical activity are associ-
ated with a lower risk of CV events [1, 2] and elite 
athletes live longer than the general population [3]. 
Nevertheless, there is debate on the dose-response 
relationship of exercise and CVD outcomes [4, 5] 
and whether high volumes of exercise may acceler-
ate coronary atherosclerosis [6, 7]. Nonetheless, 
CV prevention is in the first instance preferable by 
lifestyle changes, and many studies have shown 
an inverse association between physical activity 
level and the incidence of CVDs suggesting low 
aerobic fitness as a strong predictor for future CVD 
and all-cause mortality in both healthy and CVD 
patients [8, 9].
We read with great interest the very informa-
tive and well-performed landmark editorial from 
Kaleta et al. [10] recently published on ‘Cardiol-
ogy Journal’ and the presented paper completely 
concurs with the authors. A growing segment of 
the global population chooses to participate in 
high levels of strenuous exercise for a myriad of 
reasons, including athletic performance, socializa-
tion, and weight management. Epidemiological data 
examining prior elite athletes, a group that by defi-
nition engages in exceptionally high exercise doses 
with respect to frequency, duration, and intensity 
during their first few decades of life, consistently 
document desirable late-life outcomes. On the 
contrary, there has been more recent concern that 
high levels of strenuous exercise may do more 
harm than good. It has been suggested that at the 
upper end of the exercise dose–response curve for 
mortality may be reverse J or even U shape with 
the highest exercise doses reducing or completely 
eliminating the tangible health benefits afforded by 
lower doses; it must be reminded that assessment 
of mortality risk for the upper end of exercise dose 
is hindered by the fact that most population-based 
cohort studies have relatively few individuals who 
exercise at doses that substantially exceed physical 
activity recommendations. Furthermore, although 
it remains unclear whether vigorous, long-term 
endurance exercise may accelerate atherosclero-
sis or cause adverse cardiac remodeling in some 
people, it is well-established that acute bouts of 
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physical exercise transiently increase the risk of 
sudden death. These findings emphasize the po-
tential importance of conservative exercise dose 
recommendations among patients with established 
CVD in secondary prevention clinical settings, also 
advocating cardiac rehabilitation programs to pro-
vide a useful resource for starting and tailoring an 
exercise program in patients with established CVD.
Current exercise specific dose recommen-
dation of 150 min of moderate-intensity weekly 
exercise is based on the observation that 2 h to 2.5 h 
of moderate-intensity physical activity appeared 
to be the minimum amount required to reduce 
the all-cause mortality rate and supported by 
strong literature. In the common clinical cardiology 
practice we encounter an entirely broad range of 
physical activity levels, from completely sedentary 
patients to highly active elite athletes who seek 
care in the presented sports cardiology program. 
Consequently, the assessment of physical activ-
ity habits and exercise dose exposure with each 
patient must be performed on a routine basis, and 
the use of physical activity vital signs that capture 
each element of exercise doses, including intensity, 
duration, and frequency should be endorsed.
Patients who routinely exceed physical activ-
ity recommendations are increasingly common 
both in general CV practice and in specialized 
sports cardiology programs. These patients often 
present with distinct psychosocial profiles, medi-
cal concerns, and atypical disease presentation. 
In this patient population, atypical symptoms and 
small but significant decrements in exercise ca-
pacity are frequently indicators of evolving CVD; 
it is therefore incumbent to avoid the tendency to 
minimize the importance of subjective complaints, 
particularly those of exertional symptoms and rela-
tive reductions in exercise, among patients who 
endure high levels of exercise. Moreover, patients 
who chose to exercise at high doses often do not 
uniformly adapt other healthy lifestyle choices, 
with a consequent critical need to encourage active 
screening for unhealthy dietary intake, excessive 
alcohol consumption, and unchecked exposure to 
psychological stress, as would be recommended in 
any other patient population.
As a result, exercise and physical activity, 
much like medication used in clinical practice, are 
best measured and prescribed in consideration of 
dose, which is a function of intensity, duration, and 
frequency. Physical activity guidelines are based 
on a solid epidemiological foundation, and numer-
ous randomized controlled trials are addressed to 
delineate the mechanisms by which exercise leads 
to health and longevity. In clinical CV practice, 
exercise dose and physical activity habits can and 
should be addressed with each patient with an ulti-
mate goal of individualized counselling and exercise 
prescription. Even if progress has been made, there 
is much to be learned. Refinements in  understand-
ing of how exercise dose across the spectrum af-
fects CV health are needed. Future gains can best 
be accomplished by the use of complementary 
strategies that include prioritized scientific fund-
ing, widespread application of technology designed 
to measure exercise dose both in clinical trials and 
in real-world living, and focused translational work 
geared toward delineating cellular and biochemical 
responses to exercise.
It seems mandatory to confirm, extend and 
amplify the brilliant remarks of the authors: there 
is complete agreement contained herein that it is 
unknown whether more intensive physical exercise 
enhances the CV system, whether thresholds exist, 
and which sports activities may not be beneficial. 
Given that this issue becomes more urgent due 
to the mass popularity of sport activities and the 
increasing engagement in extreme forms of endur-
ance exercise, a specific counselling with open 
discussion about both theoretical and data-driven 
risks and benefits should emphasize that exercising 
at the extreme high end of the exercise dose spec-
trum is not a prerequisite  for health optimization. 
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